Semax
Mechanism
Research
Stacks
Protocol
Safety
References
Research & Education Only — This guide is intended for educational and research reference purposes only. It does not constitute medical advice, a treatment recommendation, or a dosing protocol. Peptides listed are research compounds not approved for human therapeutic use unless otherwise specified. Always consult a qualified healthcare professional before making changes to any health or supplementation programme. No Nonsense Fitness is an information resource, not a medical provider.
TL;DR: Semax is a Russian-developed peptide related to a fragment of ACTH, studied for attention, memory and protecting the brain after injury. It has a genuinely bigger human evidence base than most peptides on this site, including Russian clinical studies in stroke recovery and glaucoma-related optic nerve damage, but almost all of that research and its clinical use has stayed inside Russia rather than being repeated in Western trials. Animal research on neuroprotection and BDNF is more extensive and consistent than the human data. It is not approved as a medicine by the HPRA or EMA, so in Ireland it is treated strictly as a research compound, and this page does not publish any dosing information.

What is Semax?

Semax is a synthetic heptapeptide, an analogue of the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10) with an additional Pro-Gly-Pro sequence. It belongs to a class of compounds investigated for their potential influence on cognitive functions and neuroprotection. Unlike ACTH, Semax lacks hormonal activity but retains the neuroregulatory properties associated with the parent molecule.

Research into Semax primarily explores its potential applications in areas related to neural plasticity, attention, memory, and resilience to stress. Its unique structure is thought to confer enhanced stability and targeted action within the central nervous system. This guide is for educational and research purposes only. Not medical advice.

How strong is the evidence?

Evidence Type Status
Human RCT ✔ (primarily in specific regions, e.g., Russia)
Observational ✔ (clinical use in specific regions)
Animal Studies
In Vitro
Regulatory Approval ✗ (not approved for human therapeutic use by HPRA/HSA or major Western regulatory bodies)

How does Semax work?

Semax is primarily understood to exert its effects through interactions within the brain's neuroregulatory systems. It is thought to modulate the activity of the melanocortin system, specifically interacting with melanocortin receptors (MC1, MC3, MC4, MC5), though its precise binding profile and downstream effects are areas of ongoing investigation. This interaction is hypothesised to influence various physiological processes, including neurogenesis, synaptic plasticity, and inflammatory responses within the central nervous system.

Further research suggests that Semax may influence the levels and activity of neurotrophic factors such as Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), which are crucial for neuronal survival, growth, and differentiation. Additionally, experimental models have indicated its potential to modulate the metabolism of monoamine neurotransmitters like dopamine, serotonin, and norepinephrine, which play key roles in mood, attention, and cognitive processes. This multifaceted interaction across several neurotransmitter and neurotrophic systems contributes to the broad spectrum of effects observed in research.

What has Semax been studied for?

Cognitive Enhancement

Research has investigated Semax for its potential to support cognitive functions, particularly in areas of attention, memory, and learning. Animal models and some human studies (e.g., in Russia) have observed improvements in sustained attention, information processing speed, and the consolidation of memory. It has been investigated for its use in subjects experiencing cognitive fatigue or following conditions that impair cognitive performance.

Neuroprotection

Semax has been studied extensively for its neuroprotective properties, primarily in animal models of neurological injury. Research suggests it may offer protection against various forms of brain damage, including ischemic stroke, traumatic brain injury, and oxidative stress. Studies have observed a reduction in neuronal damage and improved functional recovery in these experimental models, potentially through mechanisms involving antioxidant activity and the modulation of inflammatory pathways.

Mood and Stress Regulation

Experimental models have investigated Semax's potential effects on mood and stress responses. Research in rodents has observed anxiolytic-like effects and a reduction in despair behaviours associated with depression-like states. These effects are thought to be mediated by its influence on monoamine neurotransmitter systems and the hypothalamic-pituitary-adrenal (HPA) axis, contributing to enhanced resilience against various stressors.

Immune System Modulation

Beyond its direct neurological effects, Semax has been investigated for its role in modulating the immune system. In vitro and animal studies have suggested it can influence both innate and adaptive immune responses, potentially impacting inflammation and the body's general resistance. This area of research explores the intricate link between the nervous and immune systems, often referred to as neuroimmunomodulation.

What did the studies actually find?

Study / Model Reported Effect
Rat model of transient cerebral ischemia Significantly reduced neurological deficits and infarct volume.
Human study (healthy volunteers) Observed improvements in selective attention and memory recall.
In vitro (primary neuronal cultures) Increased expression of BDNF and NGF mRNA, suggesting neurotrophic support.
Animal model of chronic unpredictable stress Reduced anxiety-like behaviour and normalized levels of stress hormones.
Human study (post-stroke recovery, specific region) Faster recovery of cognitive functions and motor skills.
Mouse model of traumatic brain injury Decreased neuronal apoptosis and attenuated inflammation.
Human study (glaucoma patients, specific region) Reported improvements in visual field parameters and optic nerve function.

What has Semax been studied alongside?

  • Semax + Selank → Investigated for synergistic anxiolytic and cognitive-enhancing effects in research models.
  • Semax + N-Acetyl Cysteine (NAC) → Explored for enhanced neuroprotective and antioxidant potential in experimental settings.
  • Semax + Cerebrolysin → Studied in some research contexts for combined neurorestorative and cognitive recovery effects, particularly post-injury.
  • Semax + Noopept → Investigated for potential synergistic effects on cognitive performance and synaptic plasticity in animal models.
  • Semax + Picamilon → Examined for combined effects on stress reduction and cognitive function, especially in conditions of mental fatigue.
⚠️ Stack combinations listed for research reference only. Not safety or efficacy guidance.

I have used Semax. Here is what that is worth.

Personal experience, not guidance. I have used Semax. The amount, the frequency and the duration stay off this page for the same reason as every other compound here: those are numbers for a doctor with my bloods in front of him, not for a fitness website.

And I will be straight about what my experience is actually worth on this one. Semax is studied for focus and mental fatigue, and those are precisely the outcomes a person cannot measure honestly on himself. I knew what I had taken. I was watching for a difference. That is the weakest kind of evidence there is, and writing it up as a finding on a page whose whole claim is that it is evidence-based would be dishonest, so I am not writing it up. What I did measure was bloodwork: HDL first, then LDL and ApoB, triglycerides, haematocrit, blood pressure, liver, glucose and kidney markers, plus sleep and how I felt over weeks rather than days.

The question I put to anything before it goes near me: does this genuinely improve the result enough to justify the health cost, the financial cost, the complexity and the uncertainty? Most things fail it. What took me from over 90kg to 72kg was a calorie deficit, enough protein and consistency, and I paid a personal trainer thousands to find that out.

Why there are no doses on this page

This site does not publish doses, durations or frequencies for any compound. Published research protocols for this compound vary considerably between studies in design, intensity and duration. Those details are not something to copy from a fitness website — anyone researching this compound should read the primary literature directly and talk to a doctor who knows their bloods.

What side effects were reported?

  • Transient nasal irritation (intranasal administration).
  • Mild headache (rare).
  • Slight increase in blood pressure (rare, typically transient).
  • Minor changes in sleep patterns (rare).

No severe adverse events have been widely reported in available published literature concerning Semax research at standard experimental doses.

Semax at a glance

CAS Number
80714-61-0
Molecular Formula
C37H51N9O10
Molecular Weight
793.85 g/mol
Half-Life
Approximately 20-30 minutes (plasma, parent compound); cerebral effects may extend longer due to active metabolites and receptor modulation.
Synonyms
H-Met-Glu-His-Phe-Pro-Gly-Pro-OH, M-G-H-F-P-G-P, Heptapeptide ACTH(4-10) analogue.
Research Classification
Nootropic Peptide, Neuroprotectant, Melanocortin Receptor Modulator.

The research this page cites

  • Miasoedova NF et al. 1999 — Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke. — Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova — [Research paper]
  • Filippenkov IB et al. 2021 — Antistress Action of Melanocortin Derivatives Associated with Correction of Gene Expression Patterns in the Hippocampus of Male Rats Following Acute Stress. — International journal of molecular sciences — [Research paper]
  • Asmarin IP et al. 1997 — A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study). — Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova — [Research paper]
  • Gusev EI et al. 1997 — Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). — Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova — [Human clinical trial]
  • Kurysheva NI et al. 2001 — Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone. — Vestnik oftalmologii — [Human clinical study]
  • Gusev EI et al. 2005 — Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency. — Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova — [Human clinical study]

Frequently Asked Questions

What is Semax?

Semax is a synthetic heptapeptide derived from a fragment of ACTH (adrenocorticotropic hormone) with an added Pro-Gly-Pro sequence. It has no hormonal activity itself but is researched for effects on attention, memory and stress resilience via the melanocortin system and neurotrophic factors such as BDNF.

Is Semax approved as a medicine in Ireland or the EU?

No. Semax has a body of human clinical and observational research, but that research and its clinical use has been concentrated in Russia. It is not approved for human therapeutic use by the HPRA, the EMA or Western regulatory bodies generally, and is treated as a research compound in Ireland.

What does the human research on Semax actually cover?

Published Russian-language clinical literature includes studies in mild cognitive impairment, post-stroke recovery and optic nerve atrophy, alongside animal research on neuroprotection in ischaemic and traumatic brain injury models. This is a genuinely larger human evidence base than most research peptides have, though it comes from a specific regional research and regulatory context rather than Western multi-centre RCTs.

How is Semax typically administered in research settings?

Semax has been researched almost exclusively via intranasal administration in the published literature, rather than injection. This site does not publish dosing information for any compound; anyone researching Semax should read the primary studies and speak with a doctor familiar with their own health history.

Regulatory Note (Ireland): The Health Products Regulatory Authority (HPRA) governs medicinal products in Ireland. Research peptides are not licensed as medicines unless specifically approved. This content is provided under educational and research exemptions. Nothing on this page constitutes a product claim or therapeutic recommendation.

Research Tools — Free to Use

Reconstitution calculator, dosing-frequency planner and cycle-length calculator. No signup required.

Open the Peptide Calculators

Tracking food too? Free calorie counter with barcode scanner →